# Mechanisms of Diuretic Resistance in Heart Failure, Aim 3

> **NCT06209359** · PHASE1 · RECRUITING · sponsor: **Yale University** · enrollment: 50 (estimated)

## Conditions studied

- Heart Failure
- Diuretic Resistance

## Interventions

- **DRUG:** Ammonium Chloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06209359
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-24
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06209359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06209359, "Mechanisms of Diuretic Resistance in Heart Failure, Aim 3". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06209359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*